
Intervet International B.V. is a leading Dutch animal health company specializing in the development, manufacture, and sale of veterinary pharmaceuticals and vaccines for livestock and companion animals.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Intervet International B.V. is likely focused on expanding its vaccine portfolio, enhancing digital animal health solutions, and strengthening global supply chains in response to evolving industry demands.
Introduction of next-generation vaccines targeting emerging livestock diseases
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Intervet International B.V. develops, manufactures, and markets animal health products, including vaccines and pharmaceuticals for livestock and companion animals. The company is known for its strong research and development capabilities, holding over 4,600 patents and a robust portfolio of veterinary solutions. Intervet operates globally, maintaining compliance with stringent regulatory standards and leveraging strategic partnerships to expand its reach. As part of Merck Animal Health, Intervet benefits from significant financial backing and access to advanced scientific resources.
Boxmeer, Noord-Brabant, Netherlands
1969
Private company